Health'Breakthrough' mRNA cancer drug curbs melanoma in large trial

US drugmakers Merck and Moderna said a personalised cancer treatment reduced melanoma recurrence in a late-stage trial. Experts called the result a breakthrough, marking the first positive outcome for an mRNA cancer treatment in a large, late-stage clinical trial.

mRNA treatmentmelanomaclinical trial

FFrance 24★★★☆☆2026-08-21 09:40Original